Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 16:36 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | MA | 187 beds | Grade C | EBITDA uplift $5.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 223027 | NORFOLK, MA | 187 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 187-bed suburban community hospital in NORFOLK, MA with $73.5M in net patient revenue and a 19.6% operating margin. The hospital serves a payer mix of 53.1% Medicare, 4.3% Medicaid, and 42.6% commercial.

Thesis: Turnaround. Our ML models identify $5.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 19.6% to 27.0% (+736bps).

Net Revenue HCRIS$73.5M
Current EBITDA COMPUTED$14.4M
Operating Margin COMPUTED19.6%
Occupancy HCRIS58.3%
Revenue / Bed COMPUTED$393K
Net-to-Gross HCRIS73.9%
Distress Probability ML53.7%

2. Market Context & Competitive Position

99
MA Hospitals
-12.2%
State Median Margin
53
Comparable Hospitals

MA has 99 Medicare-certified hospitals with a median operating margin of -12.2%. The target's margin of 19.6% places it above the state median. Among 53 size-comparable peers (94-374 beds), the median margin is -10.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (94-374), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)MA187$73.5M19.6%
LAHEY CLINIC HOSPITAL INC.MA345$991.1M-4.2%
SOUTH SHORE HOSPITALMA374$711.6M-12.0%
NEWTON WELLESLEY HOSPITALMA216$624.3M-4.7%
CAPE COD HOSPITALMA239$620.3M-1.3%
BERKSHIRE MEDICAL CENTERMA238$522.9M-12.9%
NORTH SHORE MEDICAL CENTERMA268$503.5M-12.9%
STEWARD ST. ELIZABETHS MEDICALMA244$428.5M0.7%
BEVERLY HOSPITALMA261$410.6M-1.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.5M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$894K+122bp9mo
Clean Claim Rate88.0%96.0%$47K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.5M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.5M
A/R Days Reduction
$894K
Clean Claim Rate
$47K
Total EBITDA Uplift$5.4M
Current EBITDA$14.4M
+ RCM Uplift+$5.4M
Pro Forma EBITDA$19.8M
Current Margin19.6%
Pro Forma Margin27.0%
WC Released (1x)$2.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$22.2M$149.2M6.72x46.4%
Base (11x exit)10.0x11.0x$22.2M$171.4M7.72x50.5%
Bull Case9.0x11.0x$20.0M$196.4M9.83x58.0%
Bull (12x exit)9.0x12.0x$20.0M$220.2M11.02x61.6%
Bear Case11.0x10.0x$24.4M$115.0M4.71x36.3%
Bear (11x exit)11.0x11.0x$24.4M$134.4M5.51x40.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 53.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 94-374 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-18.1% / P50=-10.1% / P75=-0.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.